← All trials
NCT04446065
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2020
- Primary completion
- Sep 30, 2021
- Completion date
- Oct 30, 2021
- First posted
- Jun 24, 2020
- Last posted
- Sep 9, 2020
- Enrollment
- 524
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- MELISA Institute Genomics & Proteomics Research SpALead sponsor
- MELISA Institute Genomics & Proteomics Research SpAReponsible party - principal investigator
- MELISA Institute Genomics & Proteomics Research SpAStudy director
- Universidad AustralCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.